Invesco’s Antares Pharma, Inc. ATRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-242,191
| Closed | -$993K | – | 4229 |
|
|
2022
Q1 | $993K | Sell |
242,191
-35,078
| -13% | -$127K | ﹤0.01% | 3076 |
|
|
2021
Q4 | $990K | Sell |
277,269
-4,448
| -2% | -$15.6K | ﹤0.01% | 3069 |
|
|
2021
Q3 | $1.02M | Buy |
281,717
+31,026
| +12% | +$125K | ﹤0.01% | 3099 |
|
|
2021
Q2 | $1.09M | Buy |
250,691
+7,658
| +3% | +$31.2K | ﹤0.01% | 3095 |
|
|
2021
Q1 | $999K | Buy |
243,033
+2,202
| +0.9% | +$9.54K | ﹤0.01% | 3055 |
|
|
2020
Q4 | $961K | Sell |
240,831
-21,521
| -8% | -$69.6K | ﹤0.01% | 2946 |
|
|
2020
Q3 | $708K | Sell |
262,352
-29,538
| -10% | -$81.7K | ﹤0.01% | 2970 |
|
|
2020
Q2 | $803K | Sell |
291,890
-41,849
| -13% | -$117K | ﹤0.01% | 2896 |
|
|
2020
Q1 | $788K | Buy |
333,739
+103,904
| +45% | +$353K | ﹤0.01% | 2834 |
|
|
2019
Q4 | $1.08M | Sell |
229,835
-77,199
| -25% | -$316K | ﹤0.01% | 2960 |
|
|
2019
Q3 | $1.03M | Sell |
307,034
-44,406
| -13% | -$146K | ﹤0.01% | 2988 |
|
|
2019
Q2 | $1.16M | Sell |
351,440
-85,723
| -20% | -$248K | ﹤0.01% | 2990 |
|
|
2019
Q1 | $1.32M | Buy |
437,163
+15,955
| +4% | +$51.7K | ﹤0.01% | 2859 |
|
|
2018
Q4 | $1.15M | Sell |
421,208
-65,790
| -14% | -$217K | ﹤0.01% | 2895 |
|
|
2018
Q3 | $1.64M | Sell |
486,998
-60,853
| -11% | -$188K | ﹤0.01% | 2891 |
|
|
2018
Q2 | $1.41M | Buy |
547,851
+491,252
| +868% | +$1.22M | ﹤0.01% | 2959 |
|
|
2018
Q1 | $125K | Buy |
56,599
+4,841
| +9% | +$10.9K | ﹤0.01% | 3653 |
|
|
2017
Q4 | $103K | Buy |
51,758
+1,844
| +4% | +$4.01K | ﹤0.01% | 3606 |
|
|
2017
Q3 | $162K | Buy |
49,914
+2,353
| +5% | +$7.26K | ﹤0.01% | 3576 |
|
|
2017
Q2 | $153K | Buy |
+47,561
| New | +$135K | ﹤0.01% | 3623 |
|
|
2016
Q2 | – | Sell |
-39,395
| Closed | -$34K | – | 3739 |
|
|
2016
Q1 | $34K | Sell |
39,395
-3,162
| -7% | -$3.06K | ﹤0.01% | 3685 |
|
|
2015
Q4 | $51K | Buy |
42,557
+1,763
| +4% | +$2.45K | ﹤0.01% | 3696 |
|
|
2015
Q3 | $69K | Sell |
40,794
-1,390
| -3% | -$2.73K | ﹤0.01% | 3708 |
|
|
2015
Q2 | $88K | Buy |
+42,184
| New | +$102K | ﹤0.01% | 3884 |
|
|
2014
Q1 | – | Sell |
-277,000
| Closed | -$1.24M | – | 4338 |
|
|
2013
Q4 | $1.24M | Hold |
277,000
| – | – | ﹤0.01% | 2970 |
|
|
2013
Q3 | $1.13M | Hold |
277,000
| – | – | ﹤0.01% | 2945 |
|
|
2013
Q2 | $1.15M | Buy |
+277,000
| New | +$1.07M | ﹤0.01% | 2765 |
|
Other funds holding ATRS
Invesco's ATRS Position: Q2 2022 in Review
Invesco sold out of Antares Pharma, Inc. (ATRS) in Q2 2022, closing a stake of 242,191 shares — an estimated $993K sold.
Invesco first reported a position in ATRS in Q2 2013 and held it in 27 quarters. The position peaked at $1.64M in Q3 2018. 1 fund tracked by Wall St. Rank holds ATRS as of Q2 2022.
- Invesco reported no remaining Antares Pharma, Inc. position as of Q2 2022 after selling out during the quarter.
- Invesco sold 242,191 Antares Pharma, Inc. shares in Q2 2022, an estimated $993K.
- Invesco first reported a position in Antares Pharma, Inc. in Q2 2013 and held it in 27 quarters.
- Invesco's Antares Pharma, Inc. position peaked at $1.64M in Q3 2018.
- 1 fund tracked by Wall St. Rank held Antares Pharma, Inc. as of Q2 2022.
Based on Invesco's 13F filing for Q2 2022, filed 15 Aug 2022.